International Conference on Hypertension & Healthcare August 11-12, 2016 Toronto, Canada

Hypertension (high blood pressure) refers to the pressure that blood applies to the inner walls of the arteries. Obesity increases the risk of the development of hypertension. The respective session mainly focuses on obesity-related hypertension, its interaction with the outcomes of hypertension, risk factors, treatment and management of obesity induced hypertension.

Obesity-associated arterial hypertension is characterized by activation of the sympathetic nervous system, activation of the renin-angiotensin system, and sodium retention, among other abnormalities. Anti-hypertension medications should be started if hypertension is diagnosed. But, with weight-loss, a significant fall in blood pressure may permit a decrease in the number of medications taken or decrease the amount of medication taken. Prevention would be better than any drug.

Given the important pathophysiologic links between weight and hypertension described, a significant increase in the prevalence of hypertension in coming years could be expected, if trends of increasing weight in the population are not stabilized and reversed.

Related Conferences:

1. 4^th Obesity & Weight Management Conference, December 07-09, 2015 Atlanta, USA
2. 5^th Obesity & Weight Management Conference, December 05-07, 2016 Philadelphia, USA
3. 3^rd Health Informatics Conference, June 27-29, 2016 New Orleans, USA
4. 6^th Global Healthcare Conference, August 22-24, 2016 Philadelphia, USA
5. Healthcare Conference, November 9-11, 2015 Dubai, UAE
6. 5^th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
7. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
8. Japanese Society of Hypertension 38^th Annual Scientific Meeting 2015, Ehime, Japan
9. Epigenetics, Obesity and Metabolism 2015, Hinxton, Cambridge, UK
10. 13^th International Congress on Obesity, Vancouver, Canada

Renal hypertension, also called renovascular hypertension, is elevated blood pressure caused by kidney disease. It is a syndrome which consists of high blood pressure caused by the kidneys' hormonal response to narrowing of the arteries supplying the kidneys (renal artery stenosis). When functioning properly this hormonal axis regulates blood pressure. Due to low local blood flow, the kidneys mistakenly increase blood pressure of the entire circulatory system. It is a form of secondary hypertension  a form of hypertension whose cause is identifiable. This session mainly accounts for the various causes and symptoms of renovascular hypertension, along with its pathogenesis, diagnosis and treatment.

Related Conferences:

1. 4^th Nephrology & Therapeutics Conference, September 14-16, 2015 Baltimore, USA
2. 6^th Nephrology & Therapeutics Conference, September 29-October 01, 2016 Miami, USA
3. 5^th Radiology Conference, September 19-20, 2016 Las Vegas, USA
4. Medical Imaging Conference, May 09-10, 2016 Chicago, USA
5. 4^th Radilogists Conference, March 17-18, 2016 London, UK
6. Austrian Society of Nephrology and Austrian Society for Hypertension Joint Meeting 2015, Alp Bach, Austria
7. 2015 Comprehensive Update in Hypertension, New York, USA 
8. Hypertension Research Conference, California, San Diego
9. Mexican College of Nephrology 49^th Congress 2015, Mazatlan, Mexico
10. 4th International Conference on Nephrology & Therapeutics, Linthicum Heights, Maryland, USA

Pulmonary hypertension (PH) is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, leading to shortness of breath, dizziness, fainting, leg swelling and other symptoms. Having pulmonary arterial hypertension (PAH) means that one has a high blood pressure in the arteries that go from the lungs to heart. Symptoms of pulmonary hypertension do not usually occur until the condition has progressed. The first symptom of pulmonary hypertension is usually shortness of breath with everyday activities, such as climbing stairs. Fatigue, dizziness, and fainting spells also can be symptoms. The molecular mechanism of pulmonary arterial hypertension (PAH) is not known yet, but it is believed that the endothelial dysfunction results in a decrease in the synthesis of endothelium-derived vasodilators such as nitric oxide and prostacyclin. Diagnosis of the severe heart condition includes mainly Echocardiography or as per the signs and symptoms of the condition.

Related Conferences:

1. 4^th Lung & Respiratory Care Conference, August 01-03, 2016 Manchester, UK
2. 5^th Pulmonologists Meeting, November 17-18, 2016 Dubai, UAE
3. 2^nd Respiratory Medicine Conference, May 09-10, 2016 Chicago, USA
4. 7^th Cardiothoracic Conference, March 29-30, 2016 Atlanta, USA
5. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
6. Pulmonary Hypertension: Next Generation 2015, London, UK
7. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA
8. Pulmonary Hypertension Summit 2016, Cleveland, Ohio, USA 
9. 2016 International Pulmonary Hypertension Conference, Dallas, USA
10. 8th Annual Meeting of the Saudi Association for Pulmonary Hypertension (SAPH) 2015, Abu Dhabi, UAE

Obesity has become an increasingly important medical problem in children and adolescents. Primary hypertension is detectable in children and adolescents and, as in adults, is associated with a positive family history of hypertension, obesity, and life-style factors.Among children and adolescents with primary hypertension; the presence of obesity was associated with marked LVH. Most childhood hypertension, particularly in preadolescents, is secondary to an underlying disorder.

The investigations have showed that children in the highest quartile of BP had significantly narrower retinal arterioles than those with lower BP, suggesting that higher BP in childhood is associated with alteration in the microvasculature. There is even emerging evidence that cognitive function is adversely affected by elevated blood pressure in childhood.

This session includes the epidemiology, incidence and pathophysiology of paediatric hypertension related with obesity, along with the cardiovascular risk factors, the onset of hypertension and obesity on children and the treatment and management of paediatric hypertension and obesity. 

Related Conferences:

1. 2^nd Pediatric Cardiology Conference, September 22-24, 2016 Las Vegas, USA
2. 4^th Pediatrics Conference, March 29-31, 2016 Atlanta, USA
3. Pediatric Dermatology Conference, October 10-12, 2016 Manchester, UK
4. Pediatric Emergency Medicine Conference, March 29-31, 2016 Atlanta, USA
5. Pediatric Oncology Conference, August 04-06, 2016 Toronto, Canada
6. 9th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2016, San Francisco, CA
7. Pediatric and Adult Intervention Cardiac Symposium 2015, Las Vegas, USA
8. Echocardiography in Pediatric and Adult Congenital Heart Disease 2015, Cleveland, UK
9. 11^th Advanced Symposium on Pediatric Cardiovascular Imaging 2015, Illinois, USA
10. 13^th Society for Pediatric Radiology Hands-On Cardiac MR Basic Course 2015, Chicago, USA

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20^th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.

The risk factors for Gestational hypertension comprise maternal causes like obesity, past history or adolescent pregnancy, multiple gestations, and family history. There is no specific treatment, but it is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications. Drug treatment options are limited, as many antihypertensive drugs may negatively affect the foetus. During gestational hypertension a women must be offered an integrated package of care, covering admission to hospital, treatment, measurement of blood pressure, testing for proteinuria and blood tests. 

Related Conferences:

1. Pregnancy Conference, August 29-31, 2016 Sao Paulo, Brazil
2. 2^nd Gynecology & Obstetrics Conference, November 16-18, 2015 San Antonio, USA
3. PCOS Conference, November 16-18, 2015 Seattle, USA
4. 3^rd Gynecology & Obstetrics Conference, October 17-19, 2016 Dubai, UAE
5. 2^nd PCOS Conference, October 06-08,2016 Miami,USA
6. International Society for the Study of Hypertension in Pregnancy European Congress 2015, Budapest, Hungary
7. The 2015 Pregnancy Summit, London, UK
8. 4^th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy
9. 2015 NASSHP Conference Preeclampsia and Hypertension in Pregnancy, Chicago, Illinois
10. International Federation of Placenta Associations (IFPA) 2016 Meeting, Portland, USA

High Blood Pressure has many causative factors such as age, race, family history, obesity, not being physically active, consuming tobacco, too much salt (sodium) in diet, too little potassium and vitamin D in diet, drinking too much alcohol,stress and certain chronic conditions.There are general risk factors that can be responsible for raising anyone's risk of hypertension. Although high blood pressure is most common in adults, children may be at risk, too. For some children, high blood pressure is caused by problems with the kidneys or heart. But for a growing number of kids, poor lifestyle habits, such as an unhealthy diet, obesity and lack of exercise, contribute to high blood pressure. Sometimes pregnancy contributes to high blood pressure, as well. Certain diseases and medications are specific causes of high blood pressure.

Cardiovascular disease represents the leading cause of morbidity and mortality in Western countries, and hypertension-related cardiovascular events affect about 37 million people per year, worldwide. In this perspective, hypertensive patients are at increased risk to experience cardiovascular events during life-long period, and treatment of high blood pressure represents one of the most effective strategies to reduce global cardiovascular risk.

Related Conferences:

1. 8^th Cardiologists Conference, November 14-16, 2016 San Francisco
2. Ischemic Heart Diseases Conference, May 12-13, 2016 Chicago, USA
3. Cardiovascular Imaging Conference, Nov 10-12, 2016 Istanbul, Turkey
4. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
5. 5^th Radiology & Imaging Conference, September 19-20, 2016 Las Vegas, USA
6. ICCAD 2015 — 11th International Congress on Coronary Artery Disease, Florence, Italy
7. 2015 Latin American Conference on Cardiometabolic Disease Management, Hautulco, Mexico
8. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
9. Japanese Society of Hypertension 38^th Annual Scientific Meeting 2015, Ehime, Japan
10. Coronary CT Angiography, Dallas, USA

Hypertension, or high blood pressure, is the leading risk factor associated with death in the world but is largely asymptomatic and often undetected in patients. Hypertension is typically asymptomatic and only detected through opportunistic screening. Symptoms only manifest when blood pressure reaches very high levels (usually >200 mmHg systolic), and can include headaches, dizziness and nosebleeds. It is usually diagnosed when a patient’s blood pressure is repeatedly found to be 140/90 mmHg or higher in a clinical setting and average readings taken using ambulatory blood pressure monitoring or monitoring at home are higher than 135/85 mmHg. Once hypertension has been diagnosed, further tests should be conducted, including urine testing, blood tests, an eye examination and a 12-lead electrocardiogram (ECG).Primary hypertension, in which no specific cause is found, affects 95% of patients.

Blood pressure is expressed in terms of systolic blood pressure (higher reading), which reflects the blood pressure when the heart is contracted (systole), and diastolic blood pressure (lower reading), which reflects the blood pressure during relaxation (diastole). Hypertension can be diagnosed when either systolic pressure, diastolic pressure, or both are raised.

Related Conferences:
 

1. 6^th Clinical Cardiology Conference, November 30-December 02, 2015 San Antonio, USA
2. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
3. 2^nd Pediatric Cardiology Conference, September 22-24, 2016 Las Vegas, USA
4. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
5. 8^th Clinical Cardiology Conference, November 14-16, 2016 San Francisco
6. 2016 International Pulmonary Hypertension Conference, Dallas, USA
7. Japanese Society of Hypertension 38^th Annual Scientific Meeting 2015, Ehime, Japan
8. ICTHDD 2016: 18th International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes, London, UK
9. Chinese Society of Cardiology, Shanghai, China
10. World Summit on Echocardiography, Beijing, China

Medications to treat high blood pressure includes Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors,  Angiotensin II receptor blockers (ARBs),  Calcium channel blockers and Renin inhibitors.Additional medication sometimes used to treat high blood pressure comprises Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators and Aldosterone antagonists.

No matter what medications a doctor prescribes to treat high blood pressure, lifestyle changes are required to lower blood pressure.Eating a healthier diet with less, exercising regularly, quitting smoking, limiting the amount of alcohol, maintaining a healthy weight or losing weight must be followed up to control high blood pressure. 

Related Conferences:

1. Cardiovascular Imaging Conference, Nov 10-12, 2016 Istanbul, Turkey
2. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
3. 7^th Cardiothoracic Conference, March 29-30, 2016 Atlanta, USA
4. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
5. 6^th Clinical Cardiology Conference, November 30-December 02, 2015 San Antonio, USA
6. Hypertension Summit 2015, London, UK
7. The 6th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus (FIXED 2015), Berlin, Germany
8. British Society of Echocardiography, Birmingham, U.K.
9. Multi-modality Cardiovascular Imaging for the Clinician, Houston, Texas
10. Transcatheter Cardiovascular Therapeutics, San Francisco, California

Complications of hypertension are clinical outcomes that result from persistent elevation of blood pressure. Hypertension is a risk factor for all clinical manifestations of atherosclerosis since it is a risk factor for atherosclerosis itself. It is an independent predisposing factor for heart failure, coronary artery disease, stroke, renal disease, and peripheral arterial disease. It is the most important risk factor for cardiovascular morbidity and mortality, in industrialized countries.

The various complications or manifestations arising due to high blood pressure include Hypertension Retinopathy, Primary Hypertension, Secondary Hypertension, Hypertensive Crisis, Gestational Hypertension, Ocular Hypertension and Epithelial Seizure in Children, Risk of Ischemic Heart Disease, Cognitive Impairment and Dementia, Hypertensive Nephropathy. 

Assessment of hypertension includes: Confirmation of hypertension, Risk factors, Underlying causes, End organ damage & Indications and contraindications for antihypertensive drugs.

Related Conferences:

1. Arrhythmia Conference, July 14-15, 2016 Brisbane, Australia
2. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
3. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
4. 7^th Cardiothoracic Conference, March 29-30, 2016 Atlanta, USA
5. 5^th Radiology & Imaging Conference, September 19-20, 2016 Las Vegas, USA
6. 2015 Latin American Conference on Cardiometabolic Disease Management, Hautulco, Mexico
7. Coronary Artery Disease: Case-Based Learning, Las Vegas, USA
8. Canadian Cardiovascular Congress, Toronto, Canada
9. 4th European - Middle East forum on cardiovascular risks, Budapest, Hungary
10. International Dead Sea Symposium (IDSS) on Innovations in Cardiac Arrhythmias and Device Therapy, Tel Aviv, Israel

High blood pressure, which is also called hypertension, increases the risk of developing many serious health problems, including heart disease, stroke, and kidney disease. Evaluation and Treatment of High Blood Pressure recommendations have defined “hypertension” as a BP of ≥140/90 mm Hg. The risk of cardiovascular disease in the patient with hypertension can be greatly reduced with effective antihypertensive therapy. 

Maintenance of normal body weight, following a proper diet plan, lifestyle modification including exercise, avoiding high-sodium content foods, limited alcohol consumption and appropriate medications as prescribed by the doctor may lead to a controlled and manageable blood pressure account. Also monitoring the blood pressure regularly may prevent hypertension and reduce the risk of high blood pressure-related health problems.

Related Conferences:

1. Healthcare Conference, October 05-07, 2015 New Delhi,India
2. Cardiovascular Nursing, May 05-07, 2016 Chicago, USA
3. Primary Healthcare Conference, April 25-27, 2016 Dubai,UAE
4. Clinical Nursing Conference, Nov 07-09, 2016 Melborne, Australia
5. 7^th Nursing & Healthcare Conference, August 18-20, 2016 Sao Paulo, Brazil
6. International Society of Hypertension, Seoul, South Korea
7. ICTHDD 2016: 18th International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes, London, UK
8. Hypertension Summit 2015, London, UK
9. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
10. Cardiovascular Disease Management: A Case-Based Approach, Phoenix, Ariz.

Hypertension is a powerful risk factor for fatal and nonfatal cardiovascular disease events. Data from observational studies indicate that this risk is continuous, without evidence of a threshold, down to blood pressures as low as 115/75 mm Hg. Randomized controlled trials have convincingly shown that treatment of hypertension reduces the risk of stroke, coronary heart disease, congestive heart failure, and mortality.

Various studies of hypertension control have been performed in a variety of epidemiological and practice settings.Despite the recognition that diabetic persons are at especially high risk of cardiovascular disease, studies suggest that hypertension is as poorly controlled in diabetic persons as it is in non-diabetics. Chronic kidney disease represents another comorbidity associated with both difficult blood pressure control and high cardiovascular risk. Various patient characteristics have been associated with uncontrolled hypertension, including age, obesity, and lack of exercise. These characteristics are risk factors for hypertension itself and presumably contribute directly to difficult blood pressure control.

Related Conferences:

1. Case Reports Conference, March 31-April 02, 2016 Valencia, Spain
2. 3^rd Medical Case Reports Conference, May 09-11, 2016 New Orleans, Louisiana, USA
3. 2^nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
4. Digital Pathology Conference, October 31-November 02, 2016 Valencia, Spain 
5. 5^th Pathology Conference, May 09-11, 2016 Chicago, USA
6. 4^th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy
7. 2015 Asia Pacific Conference on Cardiometabolic Diseases Management, Mumbai, India
8. 5^th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
9. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA
10. 9th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2016, San Francisco, CA

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in stroke (reduced an average of 35%-40%), heart attack (20%-25%), and heart failure (more than 50%), according to research.                            

Because hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack.Accurate diagnosis by blood pressure measurement is essential. Many advanced treatment approaches and medications have been established for the treatment and management of hypertension that may describe this session.

Related Conferences:

1. 4^th Personalized Medicine Conference, September 19-21, 2016 Phoenix, USA
2. 2^nd Molecular Medicine & Diagnosis Conference, September 26-28, 2016 Miami, USA
3. 5^th Pathology Conference, May 09-11, 2016 Chicago, USA
4. 2^nd Cytopathology Conference, August 11-12, 2016 Birmingham , UK
5. 2^nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
6. Pulmonary Hypertension: Next Generation 2015, London, UK
7. Hypertension Summit 2015, London, UK
8. 2015 International conference for innovations in cardiovascular systems, Tel Aviv, Israel
9. CARDIOTECHNIX 2015 — 3rd International Congress on Cardiovascular Technologies, Lisbon, Portugal
10. XXII. World Congress of Echocardiography and Cardiology, Istanbul, Turkey

Hypertensive people can remarkably reduce their blood pressure through nutritional changes. Increasing the amount of vegetables and fruit and reducing the amount of fat and cholesterol will not only reduce blood pressure but can help with weight loss, which also lowers blood pressure. Herbal medicines rarely have significant side effects when used appropriately and at suggested doses. Some supplements may help decrease hypertension. Apart from herbs such as Arjuna bark, olive leaf extract, and hawthorn, natural remedies like cocoa, garlic, Indian snakeroot or sarpagandha also helps in lowering hypertension.

Yoga and naturopathic lifestyle intervention aims at eliminating the root cause of the disease rather than its symptoms. Relaxation techniques such as yoga with breathing exercises can help in relaxing and reducing the stress levels and consequently lower high blood pressure. It is proven beyond doubt that regular practice of yogic lifestyle can prevent and control hypertension. Moreover, appropriate homeopathic remedy may also help in lowering high blood pressure and hypertension management.

Related Conferences:

1. Herbals & Natural Remedies Conference, October 26-27, 2015 Chicago, USA
2. Holistics Medicine Conference, July 14-15, 2016 Philadelphia, USA
3. Traditional & Alternative Medicine Conference, October 3-5, 2016 London, UK 
4. 4^th Nutrition Conference, October 26-28, 2015 Chicago, Illinois, USA
5. Natural Products Conference, October 26-28, 2015 Hyderabad, India
6. Medica World Forum for Medicine, Düsseldorf, Germany
7. Canadian Heart Rhythm Society Annual Meeting 2015, Quebec, Canada
8. Hypertension 2015, Washington, DC, USA
9. The Full Scope of Yoga: Omega Institute, Rhinebeck, New York, USA
10. Yoga for Life: Asana, Pranayama, & Meditation: Arlington, VA

High blood pressure, also known as hypertension, affects millions -- even children and teens. It is a common condition that catches up with most people who live into older age. The exact cause of hypertension is unknown, but there are several factors and conditions that may contribute to its occurrence. About one in every four adults has hypertension.

High blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

Thus, case study on patients with different forms of Hypertension, may lead to a better way of improvement in emerging ideas or techniques for treating High Blood Pressure. 

Related Conferences:

1. Case Reports Conference, March 31-April 02, 2016 Valencia, Spain
2. 3^rd Medical Case Reports Conference, May 09-11, 2016 New Orleans, Louisiana, USA
3. 2^nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
4. Digital Pathology Conference, October 31-November 02, 2016 Valencia, Spain 
5. 5^th Pathology Conference, May 09-11, 2016 Chicago, USA
6. Cardiovascular Disease Management: A Case-Based Approach, October 01-02 2015, Ariz
7. 2015 Asia Pacific Conference on Cardiometabolic Diseases Management, Mumbai, India
8. International Society of Hypertension, September 24-29 2016, South Korea
9. 5^th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
10. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA

This is a global platform that aims to connect Entrepreneurs, Proposers and the Investors all over the world. It's intended to create and facilitate the most optimized and viable business meeting place for engaging people in constructive discussions, evaluation and execution of promising business ideas. Throughout Hypertension 2016 investors would be able to find out the highest potential investment opportunities in the field of Hypertension and Treatment, which would provide a good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start or expand their business.